The Institute of Biomedical Technology (IBT) at the University of Tampere is dedicated to excel in basic and translational research and education in the field of biomedicine.
Its research activities cover diverse areas, including cancer, immunology, cellular biology, bioinformatics, biotechnology and stem cell based regenerative medicine with a common aim of developing personalized medicine via new diagnostic and treatment methods. IBT also houses FinMIT, the Academy of Finland Centre of Excellence in research on mitochondrial genetics, disease and ageing.
IBT is part of BioMediTech, a joint institute of the University of Tampere (UTA) and Tampere University of Technology (TUT). The collaboration between the universities has enabled a unique research and educational environment. In the autumn 2012 UTA and TUT launched a joint education with the objective to educate top-level experts in life sciences and medical technology.
A Postdoctoral Researcher is expected to have a suitable Doctoral degree.The successful applicant has experience in spectroscopy, preferably in Raman spectroscopy, and/or in biofunctionalization and recognition. Experience in biosensing technologies, biophysical characterization methods (such as calorimetry, AFM, fluorescence-based methods) or in chemistry (especially nanoparticles) are considered strong merits.
Applying starts: 2013-11-28 08:00
Applying ends: 2013-12-10 15:45
MSc Cristina Antonella Nadalutti: The effects of transglutaminase 2 modulation on endothelial cell biology: focus on celiac disease pathogenesis
12.12.2013 at 12 University of Tampere Arvo-building Jarmo Visakorpi -hall, Lääkärinkatu 1, Tampere.
Opponent professor Detlef Schuppan (University of Mainz).
Custos professor Markku Mäki.
More info (in Finnish)
IBT Seminar Series
Thu 12.12.2013 at 14.00-15.00 FM5 auditorium
Max Planck Institute for Brain Research
“Cortical dynamics revisited: new avenues of unraveling the neural code”